Back to all Current clinical trials
Back to all Current clinical trials
Assessment of airway clearance techniques in adults with bronchiectasis
Patients with bronchiectasis have symptoms of persistent cough and excess sputum production as a result of permanently damaged airways. Respiratory physiotherapy, in particular airway clearance techniques (ACTs), form the cornerstone in the management of bronchiectasis. However, there is a lack of valid and reliable clinimetric outcome measures to evaluate the effectiveness of various ACTs. This study aims to examine the feasibility of electrical impedance tomography in assessing the short-term effects of airway clearance in patients with bronchiectasis.
What you need to know
Inclusion criteria
- Has a diagnosis of bronchiectasis
- Productive of secretions that require routine airway clearance
- Performs ACTs regularly at home
- Willing and able to provide informed consent
Exclusion criteria
- Contraindicated for ACTs, including chest trauma, facial trauma or facial burns, bleeding disorder, uncontrolled bronchospasm, and current haemoptysis.
- Contraindicated for EIT measurements, including pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps.
- Inability to follow instructions.
- Patients less than 18 years of age.
Trial Dates
1 March to 1 October 2024
